Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women

Gynecological Endocrinology

Volumn 28, Issue 9, 2012, Pages 699-702

  Cianci, Antonio ^a   Cicero, Arrigo F G ^b   Colacurci, Nicola ^c   Matarazzo, Maria Grazia ^a   De Leo, Vincenzo ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

Berberine; Dyslipidaemia; Hypercholesterolaemia; Isoflavones; Menopausal symptoms; Menopause; Quality of life

Indexed keywords

BERBERINE; CALCIUM; COLECALCIFEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; DYSPEPSIA; FEMALE; HOT FLUSH; HUMAN; LIBIDO DISORDER; LIPOGENESIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; NAUSEA; NEPHROLITHIASIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VAGINAL DRYNESS; VASOMOTOR DISORDER;

BERBERINE; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; SINGLE-BLIND METHOD; TRIGLYCERIDES; VASOMOTOR SYSTEM;

EID: 84865339417     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.652250     Document Type: Article

References (24)

1. Mauri M, Ramacciotti D. Menopause and personal bodily changes. Minerva Ginecol 2005;57:Suppl 1:1-9.
2. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987;257:2176-2180. (Pubitemid 17055840)
3. Gambacciani M, Pepe A. Vasomotor symptoms and cardiovascular risk. Climacteric 2009;12 Suppl 1:32-35.
4. Stephenson J. FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 2003;289:537-538. (Pubitemid 37428620)
5. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006;26:2186-2191. (Pubitemid 44465710)
6. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22. (Pubitemid 30447987)
7. Messina M. Insights gained from 20 years of soy research. J Nutr 2010;140:2289S-2295S.
8. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-767S.
9. Messina M. Investigating the optimal soy protein and isoflavone intakes for women: a perspective. Womens Health (Lond Engl) 2008;4:337-356.
10. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10:1344-1351. (Pubitemid 40022716)
11. Cicero AF, Rovati LC, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterollowering agents. A single-blind clinical investigation. Arzneimittelforschung 2007;57:26-30. (Pubitemid 46212985)
12. Whitcroft S, Herriot A. Insulin resistance and management of the menopause: a clinical hypothesis in practice. Menopause Int 2011;17:24-28.
13. Dayspring TD, Pokrywka G. Impact of triglycerides on lipid and lipoprotein biology in women. Gend Med 2010;7:189-205.
14. Cicero AFG, Ertek S. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clin Lipidol 2009;4: 553-563.
15. Jun Yin, Zhanguo Gao, Dong Liu, Zhijun Liu, and Jianping, Ye Berberine improves glucose metabolism through induction of glycolysis Am J Physiol Endocrinol Metab 2008;294: E148-E156.
16. Colacurci N, Chiantera A, de Novellis V, Fornaro F, Manzella D, Arciello A et al. Soy isoflavones and endothelial function in healthy postmenopausal women. Menopause. 2005; 12 (3): 299-307. (Pubitemid 40664212)
17. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68: 1375S-1379S. (Pubitemid 28550915)
18. Kleijn de MJJ, Schouw van der YT, Wilson PWF, Grobbee DE, Jacques PF. Dietary intake of phytoestrogenes is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham Study. J Nutr 2002;132: 276-282. (Pubitemid 34135607)
19. Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 1998;12:605-623. (Pubitemid 29261274)
20. Palacios S, Rojo IA, Cancelo MJ, Neyro JL, Castelo-Branco C. Women's perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol 2008;24:178-183. (Pubitemid 351481777)
21. Caputi AP, Arcoraci V, Benvenuti C, Estronet Study group. Soy isoflavones, lactobacilli, vitamin D3 and calcium. Observational study in menopause. Gior It Ost Gin 2006;XXVIII, n. 3: 212-221. (Pubitemid 43881499)
22. Mucci M, Carraro C, Mancino P, Monti M, Papadia LS, Volpini G, Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol 2006;58:323-334. (Pubitemid 44476708)
23. Agosta C, Atlante M, Benvenuti C, Estronet Study Group. Randomized Controlled Study on Clinical Efficacy of isoflavones plus Lactobacilli, Associated or not with a Natural Anxiolytic Agent in Menopause. Minerva Ginecol. 2011: 63,1-7.
24. Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 2008;7:17.